HCPCS Level IIdrugActive
J9348
Inj. naxitamab-gqgk, 1 mg
BETOS: O1D
Effective: 2021-07-01
Description
Injection, naxitamab-gqgk, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Danyelza
Manufacturer
Y-mAbs Therapeutics, Inc.
HCPCS Dosage
1 MG
Billing Units
40.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.